Study to Assess the Efficacy, Safety, and Tolerability of AZD8529 in Adult Schizophrenia Patients
Clinical trial NCT00921804 · COMPLETED
Trial details
- NCT number
- NCT00921804
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-01
- Primary completion
- 2010-05-01
- Enrollment
- 296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.